Drug intelligence / Profile preview

WO 5000

Development stage: Preclinical
Lead developer: Dr August Wolff
Modality: Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

WO 5000 is a topical dermatological preparation, specifically a body lotion with a pH of 4, developed by Dr. August Wolff GmbH & Co. KG Arzneimittel. It is being investigated for its ability to strengthen the skin barrier, induce epidermal differentiation, and reduce inflammation through pH normalization via acidification.

Beyond the preview

Go deeper on WO 5000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WO 5000.

Explore the full profile